The value of defining molecular resistance in patients with progressive EGFR and ALK-driven lung cancer in a public system.Carly C. Barron,Tracy Stockley,Jennifer H. Law,Muqdas Shabir,Roxanne Fernandes,Tong Zhang,Lisa W. Le,Ming Sound Tsao,Suzanne Kamel-Reid,Prodipto Pal,Michael Cabanero,Joerg Schwock,Hyangmi Ko,Geoffrey Liu,Penelope Ann Bradbury,Adrian G. Sacher,Frances A. Shepherd,Natasha B. Leighl,Kirstin PerdrizetJOURNAL OF CLINICAL ONCOLOGY(2021)引用 0|浏览17暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要